Invivyd (IVVD) Shares Outstanding (Weighted Average) (2020 - 2025)

Invivyd (IVVD) reported Shares Outstanding (Weighted Average) of $172.2 million for Q4 2025, up 45.26% on a YoY basis from $118.6 million in Q4 2024, and up 25.82% quarter-over-quarter from $136.9 million in Q3 2025.

Invivyd (IVVD) Shares Outstanding (Weighted Average) (2020 - 2025) Analysis & Trends

Invivyd has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $172.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 45.26% year-over-year to $172.2 million; the trailing twelve-month figure through Dec 2025 stood at $172.2 million (up 45.26% YoY), and the FY2025 full-year result was $172.2 million, up 45.26% from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 stood at $172.2 million, up from $136.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $172.2 million in Q4 2025, with the low at $249769.0 in Q2 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $104.9 million across 5 years, with a median of $109.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) surged 43206.77% — and 2023, when it rose 0.84%.
  • Invivyd's Shares Outstanding (Weighted Average) stood at $42.6 million in 2021, then jumped by 154.02% to $108.3 million in 2022, then rose by 1.16% to $109.5 million in 2023, then gained by 8.24% to $118.6 million in 2024, then soared by 45.26% to $172.2 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $172.2 million (Q4 2025), $136.9 million (Q3 2025), and $120.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Invivyd 168.41 Mn -58.28 Mn - 172.21 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 172.21 Mn
Sep 30, 2025 136.87 Mn
Jun 30, 2025 119.95 Mn
Mar 31, 2025 119.88 Mn
Dec 31, 2024 118.56 Mn
Sep 30, 2024 118.16 Mn
Jun 30, 2024 117.49 Mn
Mar 31, 2024 115.62 Mn
Dec 31, 2023 109.53 Mn
Sep 30, 2023 109.33 Mn
Jun 30, 2023 109.12 Mn
Mar 31, 2023 108.79 Mn
Dec 31, 2022 108.27 Mn
Sep 30, 2022 108.42 Mn
Jun 30, 2022 108.17 Mn
Mar 31, 2022 107.87 Mn
Dec 31, 2021 42.62 Mn
Sep 30, 2021 61.30 Mn
Jun 30, 2021 249,769.00
Dec 31, 2020 3.61 Mn